[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteoarthritis-of-the-shoulder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteoarthritis-of-the-shoulder":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100398441","clinical-results-and-rsa-migration-analysis-of-the-global-icon---stemless-anatomic-shoulder-100398441",false,"NCT04468178","Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder","Inclusion Criteria:\n\n1. Trial participants need primary total shoulder replacement due to primary osteoarthritis or post-traumatic osteoarthritis\n2. Trial participants are willing to take part in the clinical trial and intend to be available for the planned follow-up examinations.\n3. Male, female and various subjects with age on the day of surgery from 18 to 80 years inclusive.\n4. Subjects agree not to participate in any other clinical trial for at least 2 years (+ 3 weeks) using the index procedure. This includes clinical trials of medication, invasive procedures and medical devices. Questionnaire-based studies or other studies that are non-invasive and do not involve drug use are allowed.\n5. Exclusion of intraoperative circumstances that require the implantation of a prosthesis type other than that provided for in the clinical trial (depending on the surgeon).\n\nExclusion Criteria:\n\n1. Previous operation on the rotator cuff of the affected shoulder\n2. Dysfunctional rotator cuff\n3. Infection of the affected shoulder joint or systemic infection\n4. Pregnant or breastfeeding women and those who are planning to become pregnant for up to 2 years (+3 weeks) using the index procedure","ALL","18 Years","80 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The primary goal of the clinical trial is to determine that the GLOBAL ICON implant system from DePuy does not exhibit worse shoulder function after 2 years than the SIMPLICITY from Wright Medical. The primary endpoint is the Constant-Murley Shoulder Score (CMSS) of the implant after 2 years, the non-inferiority of which is to be demonstrated in comparison with an already established prosthetic system (SIMPLICITY, Wright Medical).",[26],"Osteoarthritis of the Shoulder",[28,29,30],"osteoarthritis","shoulder","joint replacement","RECRUITING","2025-03-21",{"date":34,"type":35},"2025-03-25","ACTUAL",{"date":37,"type":35},"2021-09-17",{"date":39,"type":20},"2027-12-31",{"name":41,"class":42},"Hannover Medical School","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":15,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":62,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100380040","tsa-vs-rsa-in-glenohumeral-osteoarthritis-100380040","NCT04228419","TSA vs RSA in Glenohumeral Osteoarthritis","Study Evaluating Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis: Protocol","SERVASA","Inclusion Criteria:\n\n1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:\n\n   1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs\n   2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)\n   3. Activity modification\n2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss\n3. Patients may present with a glenoid deficiency and \\\u003C\u002F=15 degrees of retroversion\n4. 65 years of age and older\n\nExclusion Criteria:\n\n1. Active joint or systemic infection\n2. Rotator cuff arthropathy\n3. Significant muscle paralysis\n4. Charcot's arthropathy\n5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)\n6. Unable to understand the consent form\u002Fprocess\n7. Pregnancy\n8. Psychiatric illness that precludes informed consent\n9. Unwilling to be followed for the duration of the study\n10. Retroversion cannot be surgically corrected to within 10 degrees of neutral\n11. History of previous shoulder surgery on affected side","65 Years",{"count":54,"type":20},108,[23],"This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.",[26],[59,60,61],"arthroplasty","glenohumeral osteoarthritis","idiopathic osteoarthritis",{"date":34,"type":35},{"date":64,"type":35},"2020-03-09",{"date":66,"type":20},"2032-12-31",{"name":68,"class":42},"Ottawa Hospital Research Institute",4]